| Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
| 2020 | Effectiveness of half-a-tablet efavirenz plus 2 nucleos(t)ide reverse-transcriptase inhibitors as maintenance therapy with the guidance of therapeutic drug monitoring among virologically suppressed HIV-positive patients: A prospective study | Huang S.-H.; SHU-WEN LIN ; SUI-YUAN CHANG ; Lin Y.-T.; HSIN-YUN SUN ; Liu W.-C.; Su Y.-C.; CHIEN-CHING HUNG ; SHAN-CHWEN CHANG | Journal of Microbiology, Immunology and Infection | 4 | 4 | |
| 2023 | Effectiveness of second-generation integrase strand-transfer inhibitor-based regimens for antiretroviral-experienced people with HIV who had viral rebound | Chen, Guan-Jhou; HSIN-YUN SUN ; SUI-YUAN CHANG ; SZU-MIN HSIEH ; WANG-HUEI SHENG ; YU-CHUNG CHUANG ; YU-SHAN HUANG ; KUAN-YIN LIN ; Liu, Wen-Chun; Su, Yi-Ching; CHIEN-CHING HUNG | Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi | 0 | 0 | |
| 2019 | Effectiveness of switching from protease inhibitors to dolutegravir in combination with nucleoside reverse transcriptase inhibitors as maintenance antiretroviral therapy among HIV-positive patients | Chen G.-J.; HSIN-YUN SUN ; SUI-YUAN CHANG ; ARISTINE CHENG ; YU-SHAN HUANG ; KUAN-YIN LIN ; YI-CHIA HUANG ; Su Y.-C.; Liu W.-C.; CHIEN-CHING HUNG | International Journal of Antimicrobial Agents | 18 | 17 | |
| 2012 | An efficient, mild and scalable synthesis of bioactive compounds containing the angelicin scaffold | Shiao H.-Y.; Kuo C.-C.; Horng J.-T.; Shih S.-R.; SUI-YUAN CHANG ; Liao C.-C.; Hsu J.-T.A.; Amancha P.K.; Chao Y.-S.; Hsieh H.-P. | Journal of the Chinese Chemical Society | 5 | 5 | |
| 2023 | Elicitation of potent neutralizing antibodies in obese mice by ISA 51-adjuvanted SARS-CoV-2 spike RBD-Fc vaccine | Li, Chia-Jung; Jiang, Chung-Lin; TAI-LING CHAO ; Lin, Shiau-Yu; Tsai, Ya-Min; Chao, Chong-Syun; Su, Yu-Ting; Chen, Chun-Jen; SUI-YUAN CHANG ; FU-JUNG LIN ; SHIH-CHUNG CHANG | Applied microbiology and biotechnology | 1 | 1 | |
| 2011 | Emerging HIV-1 resistance to tipranavir and darunavir in patients with virological failure to first-generation protease inhibitors in Taiwan | SZU-MIN HSIEH ; SUI-YUAN CHANG ; CHIEN-CHING HUNG ; WANG-HUEI SHENG ; Chen M.-Y.; SHAN-CHWEN CHANG | International Journal of STD and AIDS | 2 | 2 | |
| 2020 | Endo-Lysosomal Cation Channels and Infectious Diseases | Chao, Yu-Kai; SUI-YUAN CHANG ; Grimm, Christian | Reviews of physiology, biochemistry and pharmacology | 13 | 0 | |
| 2022 | Endolysosomal cation channels point the way towards precision medicine of cancer and infectious diseases | CHENG-CHANG CHEN ; Krogsaeter, Einar; CHING-YING KUO ; MIN-CHUAN HUANG ; SUI-YUAN CHANG ; Biel, Martin | Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie | 5 | 4 | |
| 2020 | Enhancement of the IFN-β-induced host signature informs repurposed drugs for COVID-19 | Huang, Chen-Tsung; TAI-LING CHAO ; Kao, Han-Chieh; Pang, Yu-Hao; Lee, Wen-Hau; Hsieh, Chiao-Hui; SUI-YUAN CHANG ; Huang, Hsuan-Cheng; Juan, H.-F. | Heliyon | 16 | 15 | |
| 2012 | Entamoeba histolytica infection in men who have sex with men | CHIEN-CHING HUNG ; SUI-YUAN CHANG ; Ji D.-D. | The Lancet Infectious Diseases | 97 | 75 | |
| 2011 | Enterovirus-induced miR-141 contributes to shutoff of host protein translation by targeting the translation initiation factor eIF4E | Ho B.-C.; SUNG-LIANG YU ; Chen J.J.W.; SUI-YUAN CHANG ; BO-SHIUN YAN ; Hong Q.-S.; Singh S.; CHUAN-LIANG KAO ; Chen H.-Y.; KANG-YI SU ; Li K.-C.; Cheng C.-L.; Cheng H.-W.; Lee J.-Y.; Lee C.-N.; PAN-CHYR YANG | Cell Host and Microbe | 134 | 127 | |
| 2012 | Evaluation of macrolide resistance and enhanced molecular typing of Treponema pallidum in patients with syphilis in taiwan: A prospective multicenter study | Wu H.; SUI-YUAN CHANG ; Lee N.-Y.; Huang W.-C.; Wu B.-R.; Yang C.-J.; Liang S.-H.; Lee C.-H.; Ko W.-C.; Lin H.-H.; Chen Y.-H.; Liu W.-C.; Su Y.-C.; Hsieh C.-Y.; Wu P.-Y.; CHIEN-CHING HUNG | Journal of Clinical Microbiology | 40 | 35 | |
| 2017 | Evaluation of performance of human immunodeficiency virus antigen/antibody combination assays in Taiwan | Chang C.-K.; Kao C.-F.; Lin P.-H.; Huang H.-L.; Ho S.-Y.; Wong K.-C.; Lin B.-C.; Yeh C.-C.; Lee C.-Y.; CHUAN-LIANG KAO ; Lee C.-N.; SUI-YUAN CHANG ; Yang J.-Y. | Journal of Microbiology, Immunology and Infection | 3 | 2 | |
| 2022 | Evolution of anti-SARS-CoV-2 spike protein titers after two-dose of COVID-19 vaccination among people living with HIV | WANG-DA LIU ; Pang, Man Wai; JANN-TAY WANG ; HSIN-YUN SUN ; YU-SHAN HUANG ; KUAN-YIN LIN ; UN-IN WU ; Li, Guei-Chi; Liu, Wen-Chun; Su, Yi-Ching; He, Pu-Chi; Lin, Chia-Yi; Yeh, Chih-Yu; Cheng, Yu-Chen; Yao, Yi; Chen, Yi-Ting; Wu, Pei-Ying; Chen, Ling-Ya; Luo, Yu-Zhen; Chang, Hsi-Yen; WANG-HUEI SHENG ; SZU-MIN HSIEH ; SUI-YUAN CHANG ; CHIEN-CHING HUNG ; SHAN-CHWEN CHANG | Journal of virus eradication | 3 | 2 | |
| 2007 | Evolution of hepatitis B serological markers in HIV-infected patients receiving highly active antiretroviral therapy | WANG-HUEI SHENG ; JIA-HORNG KAO ; PEI-JER CHEN ; LI-MIN HUANG ; SUI-YUAN CHANG ; HSIN-YUN SUN ; CHIEN-CHING HUNG ; Chen M.-Y.; SHAN-CHWEN CHANG | Clinical Infectious Diseases | 72 | 66 | |
| 2022 | Evolution of Hepatitis B Virus (HBV) Serologic Markers Among Antiretroviral-Naive Young People Living With Human Immunodeficiency Virus Who Had Undergone Neonatal HBV Vaccination and Initiated Antiretroviral Therapy | YI-CHIA HUANG ; HSIN-YUN SUN ; WANG-HUEI SHENG ; SZU-MIN HSIEH ; Huang, Sung Hsi; Chen, Guan Jhou; WANG-DA LIU ; SUI-YUAN CHANG ; Su, Yi Ching; Su, Li Hsin; Liu, Wen Chun; CHIEN-CHING HUNG | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 0 | 0 | |
| 2023 | Evolution of neutralizing antibodies and cross-activity against different variants of SARS-CoV-2 in patients recovering from COVID-19 | WANG-DA LIU ; JANN-TAY WANG ; TAI-LING CHAO ; Ieong, Si-Man; Tsai, Ya-Min; Kuo, Po-Hsien; MING-JUI TSAI ; Chen, Yi-Jie; Li, Guei-Chi; Ho, Shu-Yuan; Chen, Hui-Hou; YU-SHAN HUANG ; CHIEN-CHING HUNG ; YEE-CHUN CHEN ; SUI-YUAN CHANG ; SHAN-CHWEN CHANG | Journal of the Formosan Medical Association = Taiwan yi zhi | 0 | 0 | |
| 2021 | Evolution of SARS-CoV-2 neutralizing antibody in an HIV-positive patient with COVID-19 | WANG-DA LIU ; CHIEN-CHING HUNG ; JANN-TAY WANG ; MING-JUI TSAI ; Kuo, Po-Hsien; TAI-LING CHAO ; SZU-MIN HSIEH ; WANG-HUEI SHENG ; YEE-CHUN CHEN ; SUI-YUAN CHANG ; SHAN-CHWEN CHANG | Journal of the Formosan Medical Association = Taiwan yi zhi | 3 | 1 | |
| 2021 | Experience of the use of hydroxychloroquine on patients with COVID-19: A perspective on viral load and cytokine kinetics | WANG-DA LIU ; SUI-YUAN CHANG ; Lan, Ting-Yuan; Lin, Yen-Chun; JUI-HUNG KAO ; Liao, Chun-Hua; MING-JUI TSAI ; Kuo, Po-Hsien; YU-SHAN HUANG ; JANN-TAY WANG ; WANG-HUEI SHENG ; SONG-CHOU HSIEH ; BOR-LUEN CHIANG ; YEE-CHUN CHEN ; SHAN-CHWEN CHANG | Journal of the Formosan Medical Association | 5 | 2 | |
| 2023 | Factors associated with viral rebound among COVID-19 patients receiving oral antivirals | PAO-YU CHEN ; JANN-TAY WANG ; SUI-YUAN CHANG ; CHIEN-CHING HUNG ; CHI-TAI FANG ; ARISTINE CHENG ; WANG-DA LIU ; YU-SHAN HUANG ; KUAN-YIN LIN ; HSIN-YUN SUN ; SUNG-CHING PAN ; Cheng, Yu-Cheng; Wang, Hurng-Yi; WANG-HUEI SHENG ; YEE-CHUN CHEN ; YI-LWUN HO ; Wu, Ming-Shiang; SHAN-CHWEN CHANG | Journal of the Formosan Medical Association = Taiwan yi zhi | 1 | 0 | |
